Efficacy and safety analysis of angiotensin receptor neprilysin inhibition(ARNI)in patients with heart failure: a real-world retrospective study

BACKGROUND: In a large randomized controlled trial (PARADIGM-HF), ARNI has been shown to significantly reduce cardiovascular mortality and hospitalization for patients with reduced ejection fraction in heart failure. This study analyzed the efficacy and safety of ARNI on the basis of various types o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaobo, Pu, Jun, Wang, Guixia, Xu, Hui, Liu, Liming, Li, Zhen, Qin, Ruijie, Zhao, Xuemei, Li, Ming, Hao, Zedong, Hu, Houxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334639/
https://www.ncbi.nlm.nih.gov/pubmed/37430227
http://dx.doi.org/10.1186/s12872-023-03374-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334639/
https://www.ncbi.nlm.nih.gov/pubmed/37430227
http://dx.doi.org/10.1186/s12872-023-03374-w

Ejemplares similares